Nan Wei
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Soft tissue surface deformation detection in endoscopic images.
Journal: iScience
Published: October 30, 2025
LOXL2 serves as a prognostic biomarker associated with immune landscape in lung adenocarcinoma.
Journal: Asian journal of surgery
Published: September 16, 2024
Synergistic therapeutic efficacy and safety of sequential radiotherapy and anlotinib therapy in advanced central squamous cell lung cancer.
Journal: Asian journal of surgery
Published: June 13, 2024
CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
Journal: Frontiers in bioscience (Landmark edition)
Published: January 06, 2024
Pulmonary infection with Aeromonas dhakensis in a patient with acute T lymphoblastic leukemia: a case report and review of the literature.
Journal: Frontiers in medicine
Published: December 18, 2023
Reporting quality evaluation of clinical practice guidelines for pulmonary nodules with the RIGHT checklist.
Journal: Chinese medical journal
Published: December 11, 2023
Advances in the Treatment of Pulmonary Nodules.
Journal: Respiration; international review of thoracic diseases
Published: October 04, 2023
Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: June 21, 2023
Bronchoscopic transparenchymal nodule access in the diagnosis and management of pulmonary nodules.
Journal: Chinese medical journal
Published: May 10, 2023
Accurate and robust feature description and dense point-wise matching based on feature fusion for endoscopic images.
Journal: Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
Published: January 18, 2021
Transcriptome Profiling of Acquired Gefitinib Resistant Lung Cancer Cells Reveals Dramatically Changed Transcription Programs and New Treatment Targets.
Journal: Frontiers in oncology
Published: April 23, 2020
Last Updated: 09/26/2026